CDK19 and liver cancer: We found that the levels of OGT, YAP, and O-GlcNAcylation in liver cancer cells with CDK19 knockout were increased compared to those treated with CA alone, suggesting that CA downregulates global O-GlcNAcylation in liver cancer cells in a CDK19-dependent manner (Supplementary Fig. 6A–C).